EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Probiotic-derived postbiotics: a perspective on next-generation therapeutics

Veilumuthu Pattapulavar, Sathiyabama Ramanujam, Bhagyashree Kini, John Godwin Christopher

Frontiers in Nutrition · 17.07.2025 · 12

DOI: 10.3389/fnut.2025.1624539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 17.07.2025. Verfasst von Veilumuthu Pattapulavar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome plays a fundamental role in regulating host immunity, metabolism, and overall health. Disruptions to this microbial ecosystem, known as dysbiosis, have been implicated in various conditions such as colorectal cancer, inflammatory bowel diseases, and metabolic syndromes. Although probiotics are widely used to restore microbial balance, their efficacy is often inconsistent due to variable colonization and concerns over antimicrobial resistance gene transfer. This review explores the growing body of literature surrounding postbiotics—bioactive metabolites produced by probiotics—as a promising alternative to live microbial therapy. We focus on key classes of postbiotics including exopolysaccharides, cell-free supernatants, short-chain fatty acids, and bacteriocins, summarizing their reported immunomodulatory, antimicrobial, antioxidant, and anti-cancer properties. We also highlight recent developments in formulation techniques, such as encapsulation, which enhance their stability and bioavailability. While current findings are promising, limitations persist, including variability in postbiotic composition and a lack of standardized clinical evaluations. Future research should aim to clarify their mechanisms of action, define optimal delivery strategies, and assess long-term safety. Overall, postbiotics present a sustainable, non-viable, and functionally rich alternative to probiotics, aligning with global health goals—Sustainable Development Goal 3 (Good Health and Well-being) and Sustainable Development Goal 9 (Industry, Innovation, and Infrastructure)—by offering safer, scalable, and effective therapeutic solutions.

Schlagwörter

Stichwörter der Autor:innen

dysbiosisgut microbiomeimmunomodulationnext-generation therapeuticspostbiotics

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
  • Faculty of Engineering, Department of Science and Humanities, Karpagam Academy of Higher Education, Coimbatore, India.

Zitieren

APA

Pattapulavar, V., Ramanujam, S., Kini, B., & Christopher, J. G. (2025). Probiotic-derived postbiotics: a perspective on next-generation therapeutics. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1624539

Vancouver

Pattapulavar V, Ramanujam S, Kini B, Christopher JG. Probiotic-derived postbiotics: a perspective on next-generation therapeutics. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1624539

BibTeX
@article{Pattapulavar2025,
  author = {Pattapulavar, Veilumuthu and Ramanujam, Sathiyabama and Kini, Bhagyashree and Christopher, John Godwin},
  title = {Probiotic-derived postbiotics: a perspective on next-generation therapeutics},
  journal = {Frontiers in Nutrition},
  year = {2025},
  volume = {12},
  doi = {10.3389/fnut.2025.1624539}
}
Kostenlos starten →